Next Investors logo grey

Abundant Produce is honing in on Chinese market

Published 26-APR-2018 11:00 A.M.

|

4 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Abundant Natural Health Pty Ltd (ANH) — a wholly owned subsidiary of Abundant Produce Limited (ASX:ABT) — has today announced that it has received approval from JD Global for the sale of ANH’s range of ActiveLycoTM infused face products and magnesium enriched nutraceuticals to Chinese consumers on JD Global’s cross border platform, JD.hk.

JD Global has approximately 293 million annual active customers, an unrivalled nationwide fulfilment network with 486 warehouses and net revenue of US$55.7 billion in 2017. It is not only China’s largest online retailer, but is also the country’s biggest overall retailer, as well as its largest internet company by revenue.

The approval includes all six SKUs of ANH’s top range ActiveLycoTM infused face products and magnesium body and salt skin ranges.

ANH’s CEO, Shanan Birkin, commented on the news: “We have worked tirelessly for this approval, particularly around the marketing and re-focusing of our products, which has been paramount in launching the products into this circle. Together with Shanghai Dragon Corporation’s (SDC) retail shop presence, we anticipate a notable lift to brand profile and sales.

“ANH’s products are sourced and made in Australia commencing in our own greenhouses at Sydney University’s campus at Cobbitty in NSW. It is all about the science of natural active ingredients, with provenance a vital element to our Chinese customers,” she said.

This latest news is part of ABT’s recently announced International Supply Agreement between ANH and Jatenergy, combined with JAT’s Cooperation Letter of Intent with Shanghai Dragon Corporation (SDC) which entailed working together towards bringing Australian products to Chinese customers.

However, this is an early stage play and as such any investment decision should be made with caution and professional financial advice should be sought.

ANH to exhibit at first ever China International Import Expo

In May last year, the Chinese President Xi Jinping announced the first China International Import Expo (CIIE) to be held in Shanghai in November 2018 — an event intended to introduce imported products to Chinese buyers and distributors.

In today’s announcement, ANH announced it will be exhibiting at the first ever CIIE, which is being viewed by many as a highly encouraging sign of support from the Chinese government for more trade liberalisation and essentially opening the market to other countries.

ANH will be promoting itself as producing high-quality Australian products, and will promoting its “Greenhouse to Gorgeous” branding as a point of difference for new customers and distributors.

This will put the company in front of an estimated 500,000 plus visitors from China and around the world, including 150,000 domestic and foreign professional purchasers for private companies, state enterprises and provincial and municipal governments.

ABT Group CEO, Tony Crimmins, said: “We will have the opportunity to demonstrate our commitment to China by showcasing ANH and its natural products and reinforcing our active participation in China’s growth. It is an important forum not only to build ANH’s brand and market its product range but it also allows us to meet other likeminded investor groups that are seeking Australian investment and joint venture possibilities.”

Products being exhibited at CIIE will include food and agricultural products, consumer electronics and home appliances, apparel, fashion and daily consumer goods, medical devices and equipment, high-end intelligent equipment and automotive products.

ANH to support Gidget Foundation Australia fundraising event

In other promising company news, ANH will next month be supporting the Annual Gidget Ladies’ Lunch, a marquee fundraising event for Gidget Foundation Australia which is being held in Sydney with support from media partner, Vogue Australia.

Gidget Foundation Australia is a not-for-profit organisation supporting the emotional wellbeing of expectant and new parents to ensure that those in need receive timely, appropriate and supportive care.

“We have donated our beautiful ActiveLycoTM infused face cream for each of the 1,500 attendees as a small gift to treat these wonderful ladies as well as two raffle prizes on the day,” Birkin said.

“Our purpose is to help bring awareness and support to this important cause, with nearly one in five mothers and one in 10 fathers experiencing perinatal depression and anxiety, which is often hidden and not fully understood.”

Crimmins added: “At Abundant Produce, we believe in making a positive contribution to our community and ultimately to all of our stakeholders. We have a strong values-based approach to our business and understand the importance of leading by example in our social corporate responsibilities.”




General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.